Skip to main content
. 2020 Oct 8;20(1):61–72. doi: 10.4103/wjnm.WJNM_50_20

Table 1.

Alzheimer’s disease patients’ details

Patients Age at presentation Neurological evaluation Duration of disease (year)

MMSE MoCA
PT1 61 19 NA 3
PT2 63 22 13 2
PT3 62 21 12 1
PT4 58 20 8 2
PT5 63 NA 10 6
PT6 76 6 NA 3
PT7 68 NA 20 2
PT8 70 11 3 5
PT9 69 NA 17 2
PT10 66 NA 23 1
PT11 67 19 13 2
PT12 69 NA 8 9
PT13 65 NA 15 1
PT14 52 NA 22 2
PT15 47 NA 19 2

MMSE: Mini-mental state examination; MoCA: Montreal cognitive assessment